| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/19/2006 | US20060014701 Novel amide derivatives as growth hormone secretagogues |
| 01/19/2006 | US20060014700 1-[2-Cyclohexyl-2-(2-methylamino-propionylamino)-acetyl]-pyrrolidine-2-carboxylic acid (2-phenyl-2H-pyrazol-3-yl)-amide; inhibitors of IAP, for treating malignancies |
| 01/19/2006 | US20060014695 Hpma-polyamine conjugates and uses therefore |
| 01/19/2006 | US20060014676 Melanocortin receptor-specific hexapeptides |
| 01/19/2006 | US20060014675 Methods for preparing internally constrained peptides and peptidomimetics |
| 01/19/2006 | US20060013860 Anticancer agents; side effect reduction |
| 01/19/2006 | US20060013794 Cosmetic or pharmaceutical composition comprising peptides with the sequences arggly-ser |
| 01/19/2006 | DE19743210B4 Rakelklinge Doctor blade |
| 01/18/2006 | EP1616963A2 Process for producing dipeptides or dipeptide derivatives |
| 01/18/2006 | EP1615954A2 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 01/18/2006 | EP1615949A1 Process for the preparation of macrocyclic compounds by ruthenium complex catalysed metathesis reaction |
| 01/18/2006 | EP1615947A2 Process for preparing macrocyclic compounds |
| 01/18/2006 | EP1615613A2 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors |
| 01/18/2006 | EP1511760B1 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 01/18/2006 | EP1307214A4 Highly homogeneous molecular markers for electrophoresis |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1071442B9 Methods and compositions for peptide synthesis (t-20) |
| 01/18/2006 | CN1723043A 造影剂 Contrast agents |
| 01/18/2006 | CN1237075C Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 01/17/2006 | US6987167 Process for production of the somatostatin analog, octreotide |
| 01/17/2006 | US6987128 Compounds of the N-acylamino amide family, compositions comprising same, and uses |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/12/2006 | WO2006003330A2 Collections of traceable compounds and uses thereof |
| 01/12/2006 | WO2005118613A3 Antibacterial amide macrocycles |
| 01/12/2006 | WO2005110456A3 T-cell death-inducing epitopes |
| 01/12/2006 | US20060009396 inhibiting platelet aggregation; for treatment of thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, angiogenesis, cancer, and neurodegenerative disorders |
| 01/12/2006 | US20060009394 alkylating a 4-protected hydroxyl pyroglutamic acid derivative with an alkylating agent to prepare a 4-protected hydroxyl-4-alkylglutamic acid derivative, followed by the steps of hydrolysis and deprotection |
| 01/12/2006 | US20060009392 Antineoplastic peptides |
| 01/12/2006 | CA2569553A1 Collections of traceable compounds and uses thereof |
| 01/11/2006 | EP1614695A1 Polypeptide |
| 01/11/2006 | EP1613958A2 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 01/11/2006 | EP1613620A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/11/2006 | EP1613339A2 Anti-fungal peptidomimetics |
| 01/11/2006 | EP1613338A2 Tamandarin analogs and fragments thereof and methods of making and using |
| 01/11/2006 | EP1613302A2 Preserved and stable compositions containing peptide copper complexes and methods related thereto |
| 01/11/2006 | EP1613294A2 Peptides and derivatives thereof as inhibitors of oxidative-induced degradation phenomena and compositions containing them |
| 01/11/2006 | EP1497283A4 Maleic acid salt of(2s)-n-(5(amino(imino)methyl)-2-thienyl)methyl-1-(2r)-2-((2r)-2-((carboxymethyl)amino)3,3-diphenylpropanoyl)-2-pyrrolidine carboxamide and a process for |
| 01/11/2006 | EP1469887A4 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/11/2006 | EP1156817A4 Controlling protein levels in eucaryotic organisms |
| 01/11/2006 | EP0827412B1 A method for radiolabeling a somatostatin-derived peptide analogue having one disulfide bond with a radioisotope of rhenium, and their therapeutical applications |
| 01/11/2006 | CN1235895C Ferfume precursor compositions and method for sending out perfume components |
| 01/10/2006 | US6984718 Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 01/10/2006 | US6984634 For prophylaxis and therapy |
| 01/10/2006 | US6984626 For therapy and prophylaxis of Alzheimer's disease |
| 01/05/2006 | WO2006001729A1 Peptide substance restoring respiratory organs function |
| 01/05/2006 | WO2006001728A1 Peptide substance restoring myocardium function |
| 01/05/2006 | WO2006001382A1 Method of producing dipeptide or dipeptide derivative |
| 01/05/2006 | WO2006001379A1 Method of producing dipeptide |
| 01/05/2006 | WO2005016280A3 Orally administered small peptides synergize statin activity |
| 01/05/2006 | US20060004184 Method and device for detecting feline immunodeficiency virus |
| 01/05/2006 | US20060004077 Inhibiting class II MHC-mediated activation of T cells; peptidomimetics of given sequence which include a Gpg (guanylpiperidyl glycine) unit; rheumatoid arthritis and/or multiple sclerosis; e.g. Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph (Cha=cyclohexylalanine, Tic=3-carboxyisoquinoline, Nle=norleucine) |
| 01/05/2006 | US20060003944 Bacterial efflux pump inhibitors and methods of treating bacterial infections |
| 01/05/2006 | US20060003943 Protease enzyme inhibitors |
| 01/05/2006 | US20060003940 T-cell death-inducing epitopes |
| 01/05/2006 | US20060003386 Metallopeptide combinatorial libraries and applications |
| 01/05/2006 | US20060003348 Omi PDZ modulators |
| 01/05/2006 | US20060002958 Attenuation of metapneumovirus |
| 01/05/2006 | DE102004062258B3 New hydroxypyrimidone, hydroxypyridinone or dihydroxybenzene derivatives useful for preparing conjugates of biomolecules useful as magnetic resonance contrast agents |
| 01/04/2006 | EP1612215A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP1150995B1 A synthetic peptide disturbing intracellular signaling |
| 01/04/2006 | EP1070083B1 Crystalline forms of 1s- [1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9- [[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino [1, 2-a][ 1,2] diazepine-1-carboxamide |
| 01/04/2006 | CN1717415A Peptide gap junction modulators |
| 01/04/2006 | CN1715295A Liquid phase synthetic method for endomorphine -1 and endomorphine -2 |
| 01/04/2006 | CN1715294A Endomorphin analog and its preparing method |
| 01/03/2006 | US6982249 using oligopeptides of given sequences to selectively inhibit thrombin-induced platelet and other cell activation |
| 01/03/2006 | US6982246 oligopeptides comprising a sequence associated with HLA-B alpha 1 domain, but comprising a tyrosine-tyrosine-tryptophan triad; preventing organ transplant rejection; side effect reduction so the patient can still fight infections |
| 01/03/2006 | US6982149 Fiber array and methods for using and making same |
| 01/03/2006 | CA2187449C Anti-cancer compounds containing cyclopentaquinazoline ring |
| 12/29/2005 | WO2005123770A1 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 12/29/2005 | WO2005123768A1 Peptide-based compounds |
| 12/29/2005 | WO2005082348A3 Inhibitors of dipeptidylpeptidase iv for regulating glucose metabolism |
| 12/29/2005 | WO2005069888A3 Smac peptidomimetics and the uses thereof |
| 12/29/2005 | WO2003071933A3 Novel compositions and methods for cancer |
| 12/29/2005 | WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer |
| 12/29/2005 | US20050288486 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
| 12/29/2005 | US20050288233 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS |
| 12/29/2005 | US20050288232 As prodrug of enalaprilat, which is a medicine useful for preventing or treating circulatory diseases such as hypertension, cardiac diseases, nephritis, and apoplexy, patches; 1-[N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline 2-hydroxyethyl ester |
| 12/29/2005 | US20050288231 Biologically active peptides as glutamate receptor inhibitors |
| 12/29/2005 | US20050288229 Bone and/or cartilage development-stimulating peptide incorporating proline or hydroxyproline; implants |
| 12/29/2005 | US20050288228 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 12/29/2005 | US20050287632 form a carboxyl-terminal amide of a desired peptide comprising contacting a substrate polypeptide and a palladium complex, where the palladium complex is a palladium(II) or palladium(IV) complex |
| 12/29/2005 | US20050287627 In presence of ATP and peptidases |
| 12/29/2005 | US20050287626 Process for producing dipeptides |
| 12/29/2005 | US20050287074 Matrix metalloproteinase inhibitors |
| 12/29/2005 | CA2568543A1 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 12/28/2005 | EP1608688A2 Branched water-soluble polymers and their conjugates |
| 12/28/2005 | EP1608674A1 Oligopeptides, composition and use thereof as elicitors of the natural defences of plants |
| 12/28/2005 | EP1608673A2 Peptides and mimetics for reducing symptoms of toxic shock syndrome and septic shock |
| 12/28/2005 | EP1265867B1 Malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 12/28/2005 | EP1157029B1 Oligopeptide derivatives for the electrochemical measurement of protease activity |
| 12/28/2005 | EP0920448B1 Truncated glial cell line-derived neurotrophic factor |
| 12/28/2005 | EP0716609B1 Methods and compositions for stimulating and inhibiting tgf-beta activity |
| 12/28/2005 | EP0662134B1 Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof |
| 12/27/2005 | US6979747 Antioxidants, preparation processes and their uses |
| 12/27/2005 | US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 12/27/2005 | US6979530 Peptide conjugates and fluorescence detection methods for intracellular caspase assay |
| 12/27/2005 | US6979436 metal and peptide complexes and/or combinatorial libraries preferential for opioids receptors, which can transit the blood-brain barrier and having improved bioavailability and pharmacokinetics; drug screening and design; analgesics |
| 12/27/2005 | CA2206799C Small molecule inhibitors of rotamase enzyme activity |
| 12/22/2005 | WO2005122379A2 Alpha-4 beta-1 integrin ligands for imaging and therapy |